LoPriore Vincent S
SEC insider (Form 3/4/5 filer). CIK 0001633927. Executive Chairman at Hepion Pharmaceuticals, Inc. (HEPA) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in RED BANK,, NJ.
Companies LoPriore Vincent S has filed insider reports for
- Hepion Pharmaceuticals, Inc. (HEPA): Director, Officer, Executive Chairman
- Tharimmune, Inc. (THAR): Director, Officer, 10% Owner, Executive Chairman
LoPriore Vincent S
CIK: 0001633927
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Sep 3, 2026HEPA
Hepion Pharmaceuticals, Inc.
PurchaseIndirectWarrants
12.5M shares- - Aug 19, 2026HEPA
Hepion Pharmaceuticals, Inc.
AwardDirectStock Options
1.3M shares- - Aug 3, 2026HEPA
Hepion Pharmaceuticals, Inc.
PurchaseIndirect2M shares at avg. $0.05$100K - Aug 3, 2026HEPA
Hepion Pharmaceuticals, Inc.
PurchaseIndirect8M shares at avg. $0.05$400K - Apr 21, 2026HEPA
Hepion Pharmaceuticals, Inc.
PurchaseIndirect5M shares at avg. $0.04$200K - Apr 21, 2026HEPA
Hepion Pharmaceuticals, Inc.
PurchaseIndirect1.3M shares at avg. $0.04$50K - Nov 3, 2025THAR
Tharimmune, Inc.
AwardDirectStock Option
90K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 |  HEPA Hepion Pharmaceuticals, Inc. | Purchase Warrants | 12,500,000 | - | - | Indirect |
| Aug 19, 2026 | HEPA Hepion Pharmaceuticals, Inc. | Award Stock Options | 1,345,500 | - | - | Direct |
| Aug 3, 2026 | HEPA Hepion Pharmaceuticals, Inc. | Purchase | 2,000,000 | $0.05 | $100,000 | Indirect |
| Aug 3, 2026 | HEPA Hepion Pharmaceuticals, Inc. | Purchase | 8,000,000 | $0.05 | $400,000 | Indirect |
| Apr 21, 2026 | HEPA Hepion Pharmaceuticals, Inc. | Purchase | 5,000,000 | $0.04 | $200,000 | Indirect |
| Apr 21, 2026 | HEPA Hepion Pharmaceuticals, Inc. | Purchase | 1,250,000 | $0.04 | $50,000 | Indirect |
| Nov 3, 2025 |  THAR Tharimmune, Inc. | Award Stock Option | 90,000 | - | - | Direct |
1-7 of 7 transactions